Skip to content
lifestyle.cosmeticsurgeryinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BD – BECTON DICKINSON/ INVESTOR RELATIONS
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
January 27, 2026
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
January 23, 2026
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
January 23, 2026
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
January 15, 2026
BD Names Shawn Bevec as Senior Vice President of Investor Relations
January 14, 2026
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
January 13, 2026
BD To Host Virtual 2026 Annual Meeting of Shareholders
January 12, 2026
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
January 5, 2026
←
Previous Page
1
2